InformAI News

HOUSTON, TEXAS, US, February 13, 2024 / EINPresswire.com / InformAI, Inc. is proud to announce that we have been awarded a grant from the National Institutes of Health (NIH). This Phase I/II Fast-Track grant (Project # 1R44HL172564-01 ) will support TransplantAI, our initiative to address the pressing issues of organ scarcity, discard, and allocation inefficiency in transplantation. The grant was awarded as part of the omnibus SBIR solicitation ( PA-22-176 ) as a Fast-Track p

InformAI is pleased to announce that we are the recipient of a supplemental product development grant from the Cancer Prevention and Research Institute of Texas (CPRIT) for $465,188 to support product development and market commercialization of our RadOncAI: AI guided dose prediction platform for radiation oncology. RadOncAI streamlines radiation treatment, speeding up the head & neck radiation therapy dose planning process while minimizing radiation exposure to healthy tissu

InformAI has been named as a finalist in the 2024 Houston Innovation Awards, an event sponsored by Houston Innovation Map which reports...

InformAI is pleased to participate alongside advisor Dr. David Sher in Chartrounds  October 28 session on personalizing radiotherapy with...

#InformAI is pleased to be a funded company at Cancer Prevention and Research Institute of Texas. Thanks to our #CPRIT Project Manager,...

Joins InformAI as Strategic Advisor HOUSTON, TX – April 3, 2024 InformAI, Inc., an AI in healthcare company based in Houston's Texas...

HOUSTON, TX – March 20, 2024  InformAI, Inc., an AI in healthcare company based in Houston's Texas Medical Center, is pleased to announce...

The National Institute of Health has bestowed a Houston medtech company with a $2.2 million Fast-Track to Phase 2 award. InformAI will...